| Current Price | $1.65 | Mkt Cap | $123.8M |
|---|---|---|---|
| Open | $1.64 | P/E Ratio | 0.00 |
| Prev. Close | $1.65 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $1.59 - $1.66 | Volume | 111,458 |
| 52-Wk Range | $1.15 - $2.87 | Avg. Daily Vol. | 191,435 |
| Current Price | $1.65 | Mkt Cap | $123.8M |
|---|---|---|---|
| Open | $1.64 | P/E Ratio | 0.00 |
| Prev. Close | $1.65 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $1.59 - $1.66 | Volume | 111,458 |
| 52-Wk Range | $1.15 - $2.87 | Avg. Daily Vol. | 191,435 |
The best Bull and Bear pitches based on recency and number of recommendations.
Strong research pipeline. Longevity is on everyone's mind.
Stock Pump and Dump. It is paying people to boost its stock, though it doesn't even have a product in stores yet, though later this year it is supposed to have some crappy vitamin on the shelves of GNC.
Read the most recent pitches from players about CDXC.
Recs
TMFSecurity
(92.84)
Submitted: 11/16/2021 9:59:23 AM :
Start Price:
$6.15
NASDAQ:CDXC Score:
+57.65
10000000146
Recs
TreasureCoastJLF
(< 20)
Submitted: 2/19/2021 11:49:15 AM :
Start Price:
$7.94
NASDAQ:CDXC Score:
-80.23
Strong research pipeline. Longevity is on everyone's mind.
Recs
futurist123
(< 20)
Submitted: 2/11/2017 7:21:20 PM :
Start Price:
$2.75
NASDAQ:CDXC Score:
-110.71
I personally bought this stock at $2.42...just getting this into CAPS now.
I like the product story behind Niagen. As of now, it seems to be a key focus and I like the story regarding how it could be a billion dollar ingredient via inclusion in other products.
The stock had two bad storylines over the course of the last year. It was hit with what amounted to a smear article on seekingalpha, which saw a precipitous drop. And recently, it announced it was suing its largest customer. I feel that customer does not have leverage over CDXC, and thus the lawsuit should be settled and return to normal operating procedure, as CDXC supplies the key ingredients for its only product as of now.
Add to all of this that the company is advised by a Nobel laureate, and we see an undervaluation.
Find the members with the highest scoring picks in CDXC.
allstar31 (99.94) Score: +265.34
Stock Pump and Dump. It is paying people to boost its stock, though it doesn't even have a product in stores yet. Later this year it is supposed to have some crappy vitamin on the shelves of GNC. Don't believe the hype.
|
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
|---|---|---|---|---|---|---|---|---|---|---|
| allstar31 | 99.94 | 7/25/2011 |
|
5Y | $5.25 | -68.76% | +196.58% | +265.34 | 2 Comments | |
| ccastineyra | 94.29 | 5/29/2012 |
|
5Y | $2.10 | -21.90% | +196.58% | +218.48 | 0 Comment | |
| MotleyViking | 97.91 | 6/8/2012 |
|
5Y | $2.01 | -18.41% | +197.61% | +216.01 | 0 Comment | |
| KnowNoFear | 27.07 | 7/20/2012 |
|
5Y | $2.19 | -25.11% | +189.03% | +214.15 | 0 Comment | |
| junkmarket | < 20 | 2/27/2012 |
|
5Y | $2.10 | -21.90% | +187.56% | +209.47 | 0 Comment | |
| minimidgy | 86.65 | 4/24/2012 |
|
5Y | $1.85 | -11.11% | +187.75% | +198.86 | 0 Comment | |
| YaelDN | 94.67 | 4/19/2012 |
|
5Y | $1.86 | -11.83% | +186.11% | +197.93 | 0 Comment | |
| Pancakes22 | 74.39 | 4/19/2012 |
|
5Y | $1.86 | -11.83% | +185.18% | +197.00 | 0 Comment | |
| FunkisMaximus | < 20 | 4/19/2012 |
|
5Y | $1.86 | -11.69% | +185.22% | +196.90 | 0 Comment | |
| MNGPHR | 58.90 | 4/16/2012 |
|
1Y | $1.80 | -8.89% | +186.81% | +195.70 | 0 Comment |
See what the Wall Street professionals think, according to their public statements and filings.
